Condition
Solid Tumor (Phase I)
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (4)
Trial Status
Not Yet Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07842445Phase 1Not Yet RecruitingPrimary
Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38.
NCT07718165Phase 1RecruitingPrimary
A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration
NCT07797907Phase 1Not Yet RecruitingPrimary
This Clinical Study is to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of BD200 in Participants With Advanced or Metastatic Cancer.
NCT07686445Phase 1Not Yet RecruitingPrimary
A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression
Showing all 4 trials